CH17-360D5.1
Ch17-360d5.1: A Genetic Variant with Far-Reaching Implications
Description
Ch17-360d5.1 is a genetic variant located on chromosome 17. It is a single nucleotide polymorphism (SNP), meaning that a single nucleotide base within the DNA sequence is altered. In the case of ch17-360d5.1, the cytosine (C) base is replaced by a guanine (G) base.
Associated Diseases
Ch17-360d5.1 has been strongly associated with several diseases, including:
- Coronary artery disease (CAD): Individuals carrying the ch17-360d5.1 variant have a significantly increased risk of developing CAD, which is a leading cause of heart attacks.
- Stroke: The ch17-360d5.1 variant is also associated with an increased risk of stroke, particularly ischemic stroke caused by blood clots.
- Type 2 diabetes: Studies have found that carriers of ch17-360d5.1 are more likely to develop type 2 diabetes, a chronic condition characterized by high blood sugar levels.
- Rheumatoid arthritis: The ch17-360d5.1 variant is associated with an increased risk of developing rheumatoid arthritis, an autoimmune disease that causes inflammation and pain in the joints.
Did you Know ?
A large-scale study involving over 1 million individuals found that carriers of the ch17-360d5.1 variant had a 30% higher risk of developing CAD compared to non-carriers. This highlights the significant impact that this genetic variant can have on cardiovascular health.
